How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

益方生物新型TYK2抑制剂D-2570(Nomelcitinib)治疗溃疡性结肠炎2期研究完成首例患者给药

calendar_today May 22, 2025 person admin domain inventisbio

5月22日,益方生物的TYK2抑制剂D-2570治疗中、重度活动性溃疡性结肠炎有效性和安全性的多中心、随机、双…

open_in_new Read original post